Energy expenditure, insulin, and VLDL-triglyceride production in humans

被引:34
作者
Gormsen, Lars C.
Jensen, Michael D.
Schmitz, Ole
Moller, Niels
Christiansen, Jens S.
Nielsen, Soren [1 ]
机构
[1] Aarhus Univ Hosp, Med Dept Endocrinol & Diabet M, DK-8000 Aarhus, Denmark
[2] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA
[3] Aarhus Univ, Dept Clin Pharmacol, DK-8000 Aarhus, Denmark
关键词
very low density lipoprotein; lipoproteins; free fatty acids;
D O I
10.1194/jlr.M600175-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hypertriglyceridemia is considered a cardiovascular risk factor in diabetic and nondiabetic subjects. In this study, we aimed to determine potential regulators of very low density lipoprotein-triglyceride (TG) production. VLDL-TG kinetics were measured in 13 men and 12 women {body mass index [mean (range)]: 24.8 (20.2-35.6) kg/m(2)}. VLDL-TG production was assessed from the plasma decay of a bolus injection of ex vivo labeled VLDL particles ([1-C-14] triolein-VLDL- TG). Similar VLDL-TG production (mu mol/min) was found in men and women. VLDL-TG production was not significantly correlated with palmitate flux ([9,10-H-3]palmitate) (r = 0.09, P = 0.67) or palmitate concentration (r = 20.29, P = 0.2) but was correlated significantly with fasting insulin concentration (r = 0.46, P < 0.05) and resting energy expenditure (REE) (r = 0.45, P < 0.05). The latter correlation improved when adjusted for sex. The best multivariate model with VLDL-TG production as the dependent variable and REE, body composition, hormones, and substrate levels as independent variables included fasting insulin (P = 0.02) and REE (P = 0.02) (r(2) = 0.32, P < 0.001).jlr We conclude that VLDL kinetics are similar in men and women and that REE and plasma insulin are significant independent predictors of VLDL-TG production. FFA availability and body fat distribution are unrelated to VLDL production. We suggest that REE plays a greater role in VLDL-TG production than previously anticipated. REE and insulin should be taken into account when VLDL-TG production comparisons between groups are made. - Gormsen, L. C., M. D. Jensen, O. Schmitz, N. Moller, J. S. Christiansen, and S. Nielsen. Energy expenditure, insulin, and VLDL-triglyceride production in humans.
引用
收藏
页码:2325 / 2332
页数:8
相关论文
共 34 条
[1]   Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia hyperinsulinemia in normal man [J].
Aarsland, A ;
Chinkes, D ;
Wolfe, RR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (09) :2008-2017
[2]   Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction [J].
Boden, G ;
Shulman, GI .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 :14-23
[3]   ESTIMATED LEAN BODY-MASS AS AN INDEX FOR NORMALIZATION OF BODY-FLUID VOLUMES IN HUMANS [J].
BOER, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 247 (04) :F632-F636
[4]   Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans [J].
Carpentier, A ;
Patterson, BW ;
Leung, N ;
Lewis, GF .
DIABETES, 2002, 51 (06) :1867-1875
[5]   The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism [J].
Carpentier, A ;
Patterson, BW ;
Uffelman, KD ;
Giacca, A ;
Vranic, M ;
Cattral, MS ;
Lewis, GF .
DIABETES, 2001, 50 (06) :1402-1413
[6]   INCREASED HEPATIC SECRETION OF VERY-LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN B-100 IN OBESITY - A STABLE-ISOTOPE STUDY [J].
CUMMINGS, MH ;
WATTS, GF ;
PAL, C ;
UMPLEBY, M ;
HENNESSY, TR ;
NAOUMOVA, R ;
SONKSEN, PH .
CLINICAL SCIENCE, 1995, 88 (02) :225-233
[7]   THE THEORETICAL BASES OF INDIRECT CALORIMETRY - A REVIEW [J].
FERRANNINI, E .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1988, 37 (03) :287-301
[8]   Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer [J].
Gormsen, LC ;
Jensen, MD ;
Nielsen, S .
JOURNAL OF LIPID RESEARCH, 2006, 47 (01) :99-106
[9]  
Guo ZK, 1997, J LIPID RES, V38, P1888
[10]  
Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014